Keyphrases
3-methoxytyramine
71%
Catecholamines
14%
Clinical Factors
14%
Diagnostic Performance
14%
Diagnostic Role
14%
Extracranial Solid Tumors
14%
High Specificity
14%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
14%
Metanephrines
42%
MS Method
14%
Neuroblastoma
100%
New Diagnostic Tools
14%
Normetanephrine
85%
Number of Patients
14%
Optimal Cutoff
14%
Pediatric Subjects
14%
Plasma Free Metanephrines
100%
Plasma Samples
14%
Prospective Clinical Study
14%
Receiver Operating Characteristic Curve
14%
Tumors in children
14%
Urinary Catecholamines
14%
Urinary Metanephrines
14%
Urine Samples
14%
Medicine and Dentistry
3-Methoxytyramine
62%
Catecholamine
25%
Clinical Study
12%
Diagnosis
25%
Diagnostic Performance
12%
Ganglioneuroblastoma
100%
Liquid Chromatography-Mass Spectrometry
12%
Metanephrine
100%
Normetanephrine
75%
Patient with Neuroblastoma
12%
Pediatrics
12%
Solid Malignant Neoplasm
12%
Tandem Mass Spectrometry
12%
Urinary System
12%
Urine Sampling
12%
Biochemistry, Genetics and Molecular Biology
3-Methoxytyramine
71%
Blood Plasma
100%
Catecholamine
14%
Catecholamine Urine Level
14%
Clinical Study
14%
Liquid Chromatography-Mass Spectrometry
14%
Normetanephrine
85%
Tandem Mass Spectrometry
14%
TSQ
14%
Urine Sampling
14%
Immunology and Microbiology
Blood Plasma
100%
Catecholamine Urine Level
14%
Liquid Chromatography Mass Spectrometry
14%
Tandem Mass Spectrometry
14%
Urine Sampling
14%